Status:
RECRUITING
Clinical Analysis of Early Hormones Between Patients With Traumatic Brain Injury and Cerebral Hemorrhage
Lead Sponsor:
General Hospital of Ningxia Medical University
Conditions:
Brain Injury Traumatic Diffuse With Loss of Consciousness
Eligibility:
All Genders
18-80 years
Brief Summary
Our understanding of neurosecretory dysfunction after TBI is still insufficient, and the number of patients with neuroendocrine dysfunction caused by craniocerebral trauma may be underestimated, espec...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old.
- The patient was clearly diagnosed as craniocerebral injury.
- The Glasgow score on admission was 3-12 (moderate and severe).
- It has complete preclinical data.
Exclusion
- Complicated with other severe visceral injuries or severe systemic fractures.
- Suffered from craniocerebral tumors, endocrine diseases, cardiovascular diseases, depression, sleep and mental disorders.
- In the past month, there are people who receive immune and hormone therapy.
- Women during pregnancy and lactation.
- Where there is a logical or common sense error in the data entered.
- The lack of too much clinical data related to this study.
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06221215
Start Date
October 1 2023
End Date
December 31 2024
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China, 750004